Delivery Order SPE2DB20D3101-SPE2DB25FRUS6
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,774.99 to AmerisourceBergen Drug Corp for Phytonadione 1 mg/0.5 mL syringes on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed-price delivery order, which carries no set-aside designation, was competitively awarded and represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. Phytonadione, commonly known as Vitamin K1, is a critical pharmaceutical used...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Phytonadione 1 mg/0.5 mL syringes with a ceiling value of $3,135.58. This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of August 13, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Phytonadione, commonly known as Vitamin K1, is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Phytonadione 1 mg/0.5 mL syringes in 0.5 mL units, valued at $3,037.93. This is a firm fixed price delivery order with no set-aside designation, utilizing competitive procurement procedures. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 22, 2025. Phytonadione, commonly...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Phytonadione 1 mg/0.5 mL syringes valued at $2,716.90, with completion targeted for July 21, 2025. This is a firm fixed-price contract with no set-aside designation, meaning it was awarded through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $10,492.26 to AmerisourceBergen Drug Corp for the supply of Phytonadione 1 mg/0.5 mL syringes in 0.5 mL units. This contract, issued on August 22, 2025, with an ultimate completion date of August 25, 2025, represents a firm fixed-price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. Phytonadione, commonly known as vitamin K1,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,141.92 to AmerisourceBergen Drug Corp for the supply of Phytonadione 1 mg/0.5 mL syringes in 0.5 mL quantities. The award, issued on August 13, 2025, with an ultimate completion date of August 14, 2025, represents a firm fixed-price delivery order with no set-aside designation. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. Phytonadione...
- The Defense Logistics Agency awarded a delivery order valued at $1,350.84 to AmerisourceBergen Drug Corp for Phytonadione 10 mg/ml ampules, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,548.82, is for the delivery of Phytonadione 1 mg/0.5 ml syrup, a medication used in the treatment of vitamin K deficiency. The contract has an ultimate completion date of December 11, 2024 and is a firm fixed-price delivery order. There is no set-aside designation for this award. AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Phytonadione 1 mg/0.5 mL syringes valued at $47,007.95. This is a firm fixed-price delivery order with no set-aside designation, placing performance at the contractor's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 4, 2025. The award represents a competitive procurement under AmerisourceBergen's existing Indefinite Delivery...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of Phytonadione 1 mg/0.5 mL syrup, a Vitamin K medication, with a ceiling value of $11,567.66 and a performance period ending on August 27, 2024. The contract is a firm fixed-price delivery order, and no set-aside designation was used. AmerisourceBergen, through its corporate office division, is the prime...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRUS6Delivery Order
The Defense Logistics Agency awarded a $21,587.42 firm fixed-price delivery order to AmerisourceBergen Drug Corp for phytonadione 1 mg/0.5 mL syringes with an ultimate completion date of September 9, 2025. Phytonadione, commonly known as vitamin K1, is a critical pharmaceutical used for blood clotting disorders and vitamin K deficiency treatment. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor for federal medical procurement needs, particularly supporting military and veteran healthcare systems. The award is executed under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which provides comprehensive global pharmaceutical support across multiple therapeutic domains. AmerisourceBergen's track record with DLA includes delivery of diverse medical commodities ranging from specialty medications and vaccines to medical devices and supplies, demonstrating the company's capability to fulfill federal healthcare supply requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.6k | 9/8/25 |